Drug Type Gene therapy |
Synonyms- |
Target |
Action modulators |
Mechanism FST modulators(Follistatin modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| disorder of aging | Preclinical | Canada | 11 Dec 2024 | |
| Muscular Atrophy | Preclinical | United States | 10 Sep 2024 | |
| Muscular Atrophy | Preclinical | Canada | 10 Sep 2024 |





